When the President decides your company is the story, you don't get to choose the timeline. Brad Dayspring on why most organizations face a decision-making problem, not a messaging problem, and what readiness actually looks like before the spotlight hits.

Announcing the promotions of team members whose contributions strengthen our culture daily and keep Purple in a category of one.

Americans believe corporate leaders are out of touch. This is how executives can reintroduce themselves to the public in a way that builds credibility while protecting their company’s reputation.

Americans aren't disengaging from values — they're redirecting them. What the rise of cause advocacy means for brands pulling back at exactly the wrong moment.

Your earnings call reaches far more than Wall Street. Learn how to prepare for the regulators, journalists, and adversaries already reading your transcript.

The Super Bowl still draws massive audiences, but they no longer watch as one. Brands face a fractured moment where reputation is tallied, not formed.

Jillayne Smyth Rogers explains why patients are turning to AI, at-home diagnostics, and self-directed care—and what healthcare populism means for leaders.

Washington's advocacy rules have changed. Learn why old tactics fail and what corporate leaders must do now to shape policy in today's environment.

New Purple Strategies research reveals 60% of Americans are bypassing the healthcare system. What the rise of health populism means for your brand.

The rules of Washington advocacy have changed. New Purple Strategies research reveals what works — and what doesn't — in the Trump 2.0 era.